$0.38786.91%-0.0288
After Hours: 0.39+0.00 +0.57%
Redhill Biopharma Ltd Adr (RDHL)
Date: 2026-10-30 16:00O: 0.3995H: 0.4100L: 0.3801C: 0.3878Vol: 109.1k
Redhill Biopharma Ltd Adr stock is traded at $0.3878, with a volume of 109,144. It is down -6.91% in the last 24 hours and down -19.21% over the past month. RedHill Biopharma Ltd is a specialty biopharmaceutical company mainly focused on the U.S. development and commercialization of drugs for GI diseases, infectious diseases, and oncology. The Company is mainly focused on the advancement of its development pipeline of clinical-stage therapeutic candidates and also commercializes its GI-related product, Talicia (omeprazole, amoxicillin, and rifabutin) in the U.S. Its therapeutic candidates include opaganib, RHB-204, RHB-104, RHB-102 (Bekinda), and RHB-107.
Previous Close:
$0.4166
Open:
$0.3995
24h Volume:
109,144
Relative Volume:
0.79
Market Cap:
$3.45M
Revenue:
$35.52M
Net Income/Loss:
$11.39M
P/E Ratio:
-
EPS:
-$2.32
Net Cash Flow:
-$26.04M
1W Performance:
-8.36%
1M Performance:
-19.21%
6M Performance:
-64.42%
1Y Performance:
-71.27%
1-Day Range:
$0.3801$0.41
1-Week Range:
$0.3801$0.449
52-Week Range:
$0.3801$1.60
Redhill Biopharma Ltd Adr Stock (RDHL) Company Profile
Compare RDHL vs TAK, TEVA, HLN, ZTS, UTHR
Redhill Biopharma Ltd Adr Stock (RDHL) Upgrades & Downgrades
Redhill Biopharma Ltd Adr Stock (RDHL) Financials Data
Revenue
Net Income
Cash Flow
EPS
Redhill Biopharma Ltd Adr Stock (RDHL) Insider Trading
- Raday GileadJul 10 '26Chief Operating Officer
- Transaction
- Sale
- Cost
- $0.00
- #Shares
- 14,130,000
- Value ($)
- 1,413
- #Shares Total
- 218,780,000
- Raday GileadApr 06 '26Chief Operating Officer
- Transaction
- Sale
- Cost
- $0.00
- #Shares
- 15,740,000
- Value ($)
- 1,574
- #Shares Total
- 261,060,000